Enzyme activity measurement showed that L-ascorbic acid (vitamin C, Vc) competitively inhibits the hyaluronan degradation by Streptococcus pneumoniae hyaluronate lyase. The complex crystal structure of this enzyme with Vc was determined at 2.0 Å resolution (PDB ID code: 1f9g). One Vc molecule was found to bind to the active site of the enzyme. The Vc carboxyl group provides the negative charges that lead the molecule into the highly positively charged cleft of the enzyme. The Vc ring system forms hydrophobic interactions with the side chain of Trp292 which is one of the aromatic patch residues of this enzyme responsible for the selection of the cleavage sites on the substrate chain. The binding of Vc inhibits the substrate binding at HA1, HA2, and HA3 catalytic positions. The high concentration of Vc in human tissues likely provides a low level of natural resistance to the pneumococcal invasion. This is the first time that Vc inhibition directly on the bacterial "spreading factor" was reported and Vc is also the first chemical that had experimentally shown to have inhibitory effect on bacterial hyaluronate lyase. These studies also highlight the possible structural requirement for the design of a stronger inhibitor of bacterial hyaluronate lyase.
Introduction not been fully characterized to date. The structural basis of the protein-Vc interface and the possible influence of Vc on enzyme activities are certainly issues of significant interest for the understanding of the functions and principles of Vc action. The proteinVc interaction was first seen in the crystal structure of D-xylose isomerase (PDB ID code: 1xid) where Vc is present between two tryptophan residues (7) . It clearly emphasizes the importance of hydrophobic interactions in the protein-Vc interface. Here we present the crystal structure of Streptococcus pneumoniae hyaluronate lyase (SpnHL) cocrystallized with Vc which provides another opportunity to examine the protein-Vc interactions at the atomic level.
S. pneumoniae is a Gram-positive bacterial pathogen which causes pneumonia, bacteremia, meningitis, sinusitis, and otitis media in humans world wide, especially in neonates and children, and often leads to significant rates of mortality and morbidity. It secretes hyaluronate lyase to catalyze the degradation of hyaluronan (HA), one of the main components of connective tissues in animals, to expose tissue cells to bacterial toxins. Therefore, SpnHL is also being called "spreading factor" (8, 9) . The inhibition of hyaluronate lyase is expected to reduce the spreading of this pathogen in the most early stages of the pneumococcal invasion. The action mechanism of hyaluronan degradation by SpnHL revealed recently provides a unique opportunity to target hyaluronate lyase in the prevention of the pneumococcal invasion. The Vc complexed crystal structure of SpnHL is an attempt on this line of research.
The enzymatic activity of SpnHL at the presence of various concentrations of Vc were measured. The crystal structure of this enzyme cocrystallized with Vc was determined at 2.0 Å resolution. The structural basis of the inhibitory effect of Vc on Hyaluronate lyase complexed with vitamin C SpnHL enzymatic activity was established.
Experimental Procedures
Crystallization and data collection  L-Ascorbic acid (Sigma) was cocrystallized with the S. pneumoniae hyaluronate lyase at conditions similar to the native SpnHL crystallization condition with additional 10 to 100 mM ascorbic acid. A dataset at 2.0 Å resolution was collected at 100 K using one crystal at 50 mM ascorbic acid, synchrotron radiation and cryocooling technique at conditions similar to the native crystal (10, 11) .
Diffraction data were processed and scaled using HKL program package (12) . The crystal belongs to the orthorhombic space group P2 1 2 1 2 1 with cell parameter a = 84.264 Å, b = 102.666 Å, c = 103.253 Å. The data set is 90.1% complete (60% in the last shell) with R sym 0.087.
Structure refinement and validation  Coordinates and B-factors of the protein part of the native SpnHL crystal structure (8) were used directly as primary model in the SpnHL-Vc complex structure refinement. All waters and solution molecules were omitted from the model. X-plor package (13) was used to refine the structure against 54,217 reflections at 2.0 to 45 Å resolution range (87.8% completeness) and 1% reflections were used in R free calculation to monitor the refinement progress and the model improvement (14) . Rigid body, position, and simulated annealing (3000 K) protocols were employed. The model was manually fitted into the electron density maps on graphics using program O (15) between each round of refinement calculations. The Hyaluronate lyase complexed with vitamin C electron densities for Vc were observed from the beginning, but Vc structure was only included into the structural refinement until the R factor dropped below 25% and water molecules were incorporated thereafter. And only after this point the B-factors refinement was introduced.
Microplate assay of SpnHL activity  The SpnHL enzymatic activity was measured using a modification of previously described protocols using either cetylpyridinium chloride (16) or cetrimide (17) . Compounds assayed for inhibitory effects on the SpnHL enzyme activity were ascorbic acid, epinephrine, apigenin, salicylic acid, and histamine (Sigma).
Volumes of 90 µl of inhibitor solutions at concentrations of 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, and 20 mM containing 50 mM sodium acetate and 10 mM calcium chloride at pH 6.0 (apigenin was dissolved in 10% DMSO water solution) were added along one row of a 96 well microtiter plate, leaving the first row as blank control. 10 µl of the wild-type SpnHL at a concentration of 3.3 µg/ml was added to each well and incubated at room temperature for 1 hour. Reactions using 40 units of bovine hyaluronidase (Sigma) at the same conditions were run in parallel. 25 µl of 1 mg/ml HA were added to each well to start the reaction which was proceeded at room temperature for 15 minutes. Undigested HA was precipitated using freshly made 50 µl of 10 % (w/v) aqueous cetylpyridinium chloride with additional 2.0% NaOH to stop the enzyme activity. The absorbance was measured at 630 nm for cetylpyridinium chloride using an automated microplate reader To determine if this inhibition is reversible, a sample of SpnHL enzyme activity was measured and designated as 100% activity. After dialyzing the sample against 20 mM Vc in buffer, the enzyme activity dropped to 0%. The sample was then dialyzed against the reaction buffer to remove the Vc, and 94% of the enzyme activity was recovered. Therefore, this inhibition is reversible. The slightly drop in activity was caused by the volume changes during dialysis.
The reaction initial velocity was measured in quadruplicate using a modified microplate assay (16) . Initial hyaluronan concentrations were 0.2, 0.1, 0.07, 0.05 and 0.04 mg/ml in 50 mM acetate buffer at pH 6.0 and 10 mM calcium chloride and 8% agarose at 55 ∞C. 100 µl of each of the 5 concentrations of the hyaluronan-agarose gel were added to the microplate columns in quadruplicate and left at room temperature for an hour to set. Solutions of SpnHL (0.33 µg/ml) with 0, 1, 5, 10 mM Vc in 10 mM calcium chloride and 50 mM acetate buffer at pH 6.0 were pre-incubated at 37 ∞C for an hour and 100 µl of each enzyme preparations were added to the first four lines of each column of the microplate. Reaction buffer was added to the remaining four lines of the microplate as control. The plates were then incubated at 37 ∞C for 14 hours. The enzyme samples were removed and each well was washed three times with the buffer. Each well was then filled with 100 µl of 2% aqueous cetrimide (hexadecyltrimethylammonium bromide) and incubated at 37 ∞C for two hours. The absorbance was measured at 405 nm Hyaluronate lyase complexed with vitamin C using an automated microplate reader (EL808; Bio-Tek Instruments, Inc., Winooski, VT).
Data deposition  Structural factors and coordinates of SpnHL-Vc complex have been deposited in the Brookhaven Protein Data Bank with accession number 1f9g.
Results
Overall structure of SpnHL-Vc complex  The crystal structure of S. pneumoniae hyaluronate lyase in complex with Vc (SpnHL-Vc complex) was determined at 2.0 Å resolution. In total, 725 out of 731 residues were modeled and 303 waters were incorporated. One Vc molecule was clearly seen in the electron density map ( Figure 1 ).
The final crystallographic R factor is 0.208 and R free 0.253. The protein part of the complex structure contains an N-terminal α-domain and a C-terminal β-domain connected by a ten residue linker. The active site of this enzyme lies in the middle of the molecule where a predominant cleft is formed between these two structural domains ( Figure 2 ). The cleft is about 30∞10 Å in dimension, enough to accommodate three disaccharide units of the hyaluronan substrate chain simultaneously, which were named HA1, HA2, and HA3 respectively from the reducing end to the non-reducing end of the hyaluronan chain (19) . The active site is located at one end of the cleft, corresponding to the reducing end of the bound hyaluronan chain and is composed of two parts, an aromatic patch responsible for the cleavage site selection on the substrate chain and a catalytic group responsible for the cleavage of the β-1,4 glycosidic linkage between HA1 Hyaluronate lyase complexed with vitamin C and HA2 disaccharide units in the hyaluronan chain (8, 19, 20) .
The protein part of the SpnHL-Vc complex structure has only slight changes when compared to the native SpnHL crystal structure. The r.m.s. deviation is only 0.538 Å for all protein atoms. In the cleft region, all corresponding atoms in the protein-Vc complex structure are located at the outer side, leaving the cleft about 0.2 Å wider than it is in the native SpnHL structure (8) . The position of Vc relative to the active site residues was shown in Figure 3a .
The aromatic patch of the enzyme active center is composed of three aromatic residues, Trp291, Trp292, and Phe343 (8) (Figure 3a) . The side chains of Trp292 and Phe343 form hydrophobic interactions with the hydrophobic patches on the hyaluronan chain. Through this matching, the cleavage sites are selected. Trp292 hydrophobically interacts with HA2 disaccharide unit and accurately anchor HA2 into catalytic position.
In the hyaluronan PAD degradation model (19) , the enzyme catalyses the degradation of the β-1,4 glycosidic linkage between HA1 and HA2 and produces 4,5-unsaturated HA1.
Vc in the SpnHL-Vc complex structure is found to bind to Trp292 (Figure 3a ) indole group and occupies the HA2 position.
The binding of Vc to SpnHL  The bound Vc forms 25 interactions with 7 residues of the enzyme (Table 1 ). These residues were also shown to interact with the substrate (8).
The relative positions of these residues to the bound Vc were shown in Figure 3b . Five out of the seven interface residues, Arg243, Asn290, Trp292, Tyr408, and Asn580, were extensively studied in our previous biochemical and structural studies and were shown to play important roles in the normal function of this enzyme (8, 20, 21) . (Table 1) . Arg243 forms one salt bridge with Vc carboxyl group. When the substrate is bound into the cleft, Arg243 interacts with HA2 and HA3 disaccharide units and with the oxygen atom of the second glycosidic linkage which is suspected to be the next glycosidic linkage to be degraded. Mutation R243V surprisingly decreased the enzyme activity by 33% (8) . In our previous studies, we proposed that Arg243 plays an important role in the substrate translocation after the initial glycosidic bond is degraded (9, 19) Therefore, Vc can be regarded as a substrate analogue of hyaluronate lyase.
The effects of these compounds on the enzyme activity of SpnHL and bovine Hyaluronate lyase complexed with vitamin C hyaluronidase were investigated and measured by the microplate enzyme activity essay.
The results showed that none of these compounds had any significant influence on the activity of bovine hyaluronidase at our experimental condition (data not shown).
However, Vc inhibited the SpnHL activity ( Figure 5 ). At our experimental condition, the IC 50 of this inhibition is about 5.8 mM.
The initial velocity of the degradation at various concentrations of hyaluronan was measured in the presence of three concentrations of Vc and in its absence. The results were fit to both the competitive model and to the noncompetitive model by nonlinear regression. The fitting attempts with the noncompetitive model repeatedly resulted in an unreasonably high value (>50,000 mM) for the parameter K i , which is not present in the competitive model. Since this parameter indicates the concentration of Vc required for the binding to the enzyme-substrate complex, it is apparent from this analysis that Vc binds only to the free enzyme (K i = 53 mM), not to the enzyme-substrate complex in the experiments described here. Therefore, the substrate competes successfully for the binding of Vc and this inhibition is competitive.
Physiological significance  The degradation of hyaluronan in the host connective tissues is an important step in the pneumococcal invasion. The bacterial strains that produce more hyaluronate lyase were shown to be more virulant than those strains producing less (24) . S. pneumoniae strains with hyaluronate lyase and cell toxin pneumolysin double mutations showed significant additive attenuation in virulence (25) . (27) , which corresponds to about 7.5 mM Vc. In the activated human neutrophils, internal Vc concentrations as high as 14 mM were detected when external vitamin is kept at physiological concentrations (28) . Therefore, the inhibitory effect of Vc on the SpnHL enzymatic activity may have a physiological meaning. It has long been known that deficiency of Vc may cause decreased resistance to some bacterial infections.
One explanation to this is that animal cells (such as neutrophils) generate oxidants to kill bacteria and using Vc to quench and control the extra oxidants released (28) The SpnHL-Vc complex structure also provides some clues for the design of a more efficient hyaluronate lyase inhibitor. Based on the interface characteristics, it can be expected that a stronger hyaluronate lyase inhibitor should have a larger ring system to benefit the hydrophobic binding to the Trp292 indole group. At least one negative charge provider, for example, a carboxyl group, is required in the inhibitor structure to provide the negative charges to lead the inhibitor into the cleft region. In summary, a stronger inhibitor can be expected to have an increased area of hydrophobic interactions and to have more properly placed negatively charged substituents such as carboxyl groups. (19, 30) . Its active center construction and geometry is nearly the same as it is in SpnHL. Therefore, the results shown may be applicable to GbsHL, which means that Vc might also provide the host with the ability to resist the S. agalactiae invasion to a certain extent. This is the first time that the direct action of Vc on a bacterial "spreading factor" has been observed. The structural basis of this inhibition is due to the structural similarity of Vc to the glucuronate residues in hyaluronan, the substrate of hyaluronate lyases. The inhibitory effect, confirmed by our enzyme activity measurements and the SpnHL-Vc complex structure studies, shows that Vc is likely directly involved in the inhibition of bacterial invasion, in addition to its antioxidant and free radical scavenger SpnHL bound Vc is in green color whereas the Vc crystal structure is in lavender color.
Large atomic displacement in the carboxyl group atoms can be seen, whereas the ring atoms change less. 
